- Home
- INTU vs ABT Comparison
INTU vs ABT Comparison
Compare INTU & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INTU
- ABT
- Stock Information
- Founded
- INTU 1983
- ABT 1888
- Country
- INTU United States
- ABT United States
- Employees
- INTU 18800
- ABT N/A
- Industry
- INTU Computer Software: Prepackaged Software
- ABT Medical/Dental Instruments
- Sector
- INTU Technology
- ABT Health Care
- Exchange
- INTU Nasdaq
- ABT Nasdaq
- Market Cap
- INTU 182.4B
- ABT 177.5B
- IPO Year
- INTU 1993
- ABT N/A
- Fundamental
- Price
- INTU $650.60
- ABT $115.93
- Analyst Decision
- INTU Buy
- ABT Buy
- Analyst Count
- INTU 19
- ABT 16
- Target Price
- INTU $734.56
- ABT $129.25
- AVG Volume (30 Days)
- INTU 1.5M
- ABT 5.2M
- Earning Date
- INTU 11-21-2024
- ABT 10-16-2024
- Dividend Yield
- INTU 0.64%
- ABT 1.90%
- EPS Growth
- INTU 23.87
- ABT 12.04
- EPS
- INTU 10.43
- ABT 3.29
- Revenue
- INTU $16,285,000,000.00
- ABT $41,217,000,000.00
- Revenue This Year
- INTU $14.39
- ABT $5.76
- Revenue Next Year
- INTU $12.30
- ABT $7.18
- P/E Ratio
- INTU $62.38
- ABT $35.24
- Revenue Growth
- INTU 13.34
- ABT 3.15
- 52 Week Low
- INTU $557.29
- ABT $99.71
- 52 Week High
- INTU $714.78
- ABT $121.64
- Technical
- Relative Strength Index (RSI)
- INTU 49.82
- ABT 49.76
- Support Level
- INTU $632.40
- ABT $115.45
- Resistance Level
- INTU $714.78
- ABT $117.94
- Average True Range (ATR)
- INTU 15.83
- ABT 2.24
- MACD
- INTU -1.09
- ABT -0.04
- Stochastic Oscillator
- INTU 42.58
- ABT 22.75
About INTU Intuit Inc.
Intuit is a provider of small-business accounting software (QuickBooks), personal tax solutions (TurboTax), and professional tax offerings (Lacerte). Founded in the mid-1980s, Intuit controls the majority of US market share for small-business accounting and do-it-yourself tax-filing software.
About ABT Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.